Pradžia › Melanoma › Minesota › Minneapolis
Melanoma klinikiniai tyrimai Minneapolis, MN
12 tyrimai dėl Melanoma ieško dalyvių vietose Minneapolis ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · už 5 mylių
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Renkami dalyviai2 fazė
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · už 5 mylių
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Renkami dalyviai2 fazė
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · už 5 mylių
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Renkami dalyviai3 fazė
- Allina Health Cancer Institute, Minneapolis
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Renkami dalyviai3 fazė
- University of Minnesota, Minneapolis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Renkami dalyviai1/2 fazė
- Minnesota Oncology and Hematology PA, Minneapolis
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Renkami dalyviai2 fazė
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- ir dar 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Renkami dalyviai1/2 fazė
- University of Minnesota/Masonic Cancer Center, Minneapolis
Project: Every Child for Younger Patients With Cancer
Renkami dalyviaiStebimasis tyrimas
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Renkami dalyviai1/2 fazė
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Renkami dalyviaiStebimasis tyrimas
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · už 5 mylių
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Renkami dalyviai3 fazė
- University of Minnesota Medical Center, Minneapolis
Melanoma tyrimai kituose miestuose
- Houston, TX59 tyrimai
- New York City, NY38 tyrimai
- Los Angeles, CA34 tyrimai
- Nashville, TN33 tyrimai
- Pittsburgh, PA31 tyrimas
- Boston, MA26 tyrimai
- Philadelphia, PA23 tyrimai
- San Francisco, CA22 tyrimai
- Durham, NC21 tyrimas
- Atlanta, GA21 tyrimas
- St. Louis, MO21 tyrimas
- Salt Lake City, UT21 tyrimas
Kiti tyrimai Minneapolis
- Krūties vėžys27 tyrimai
- Nedidelinių ląstelių plaučių vėžys26 tyrimai
- Kiaušidžių vėžys24 tyrimai
- Prostatos vėžys23 tyrimai
- Vėžys (visų tipų)22 tyrimai
- Širdies nepakankamumas21 tyrimas
- Plaučių vėžys20 tyrimai
- Ūmi mieloidinė leukemija20 tyrimai
- Storosios ir tiesiosios žarnos vėžys19 tyrimai
- Endometrio vėžys18 tyrimai
- Parkinsono liga17 tyrimai
- Širdies ir kraujagyslių ligos15 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.